PeptideDB

Betamethasone 17-benzoate

CAS: 22298-29-9 F: C29H33FO6 W: 496.57

Betamethasone 17-benzoate is a representative steroid, which can be used in the treatment of recurrent aphothous ulcers
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Betamethasone 17-benzoate is a representative steroid, which can be used in the treatment of recurrent aphothous ulcers (RAU).
Invitro Betamethasone 17-benzoate is the topical steroid[1]. Betamethasone 17-benzoate is a local corticosteroid[2]. A double-blind study of the effectiveness of Betamethasone 17-benzoate in the treatment of recurrent aphothous ulcers (RAU) is concucted. Betamethasone 17-benzoate is found to be effective in reducing symptoms and shortening healing time but not in preventing recurrences[3].
Name Betamethasone 17-benzoate
CAS 22298-29-9
Formula C29H33FO6
Molar Mass 496.57
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Barry BW, et al. Optimization of bioavailability of topical steroids: penetration enhancers under occlusion. J Invest Dermatol. 1984 Jan;82(1):49-52. [2]. ZFA (Stuttgart). 1978 Jul 10;54(19):1031-2. [3]. Merchant HW, et al. Betamethasone-17-benzoate in the treatment of recurrent aphthous ulcers. Oral Surg Oral Med Oral Pathol. 1978 Jun;45(6):870-5.